To: Jill who wrote (81 ) 4/7/2005 7:05:11 PM From: im a survivor Read Replies (1) | Respond to of 306 FLYING TO THE MOON....and then...what have we always talked about the last few weeks...it is an otc...we know very little about...mo mo cannot be ignored, as it flew very nicely for those that bought low....but, you see this and it kinda makes you wonder...think....do some numbers....anyway....I did notice RSTG up BIG AGAIN today, UNTIL this news hit, whern the sellers lined up trying to get high bids onn their sells...what does rstg do from here? I have no idea..thats why I remain out, and simply wish the longs the best of luck and hope UPWARD MO MO continues and it doesnt crater back down quickly to those gaps in the charts...but news like this is expected with OTC's....heck, I have an OTC, which I shall not name here....that has been releasing very good news....rercord revnues, growing revenues, fortune 500 customers, nice PROFIT making deals and etc, etc, etc...and it goes DOWN on good news...so, RSTG = OTC World, where ANYTHING is possible....$100 a share or $1 a share...neither would suprise me a year from now.... <<The shares of Series C Preferred Stock are convertible at the option of the Buyers into shares of Common Stock, and are initially convertible into shares of Common Stock at an initial conversion price of $24.00 per share (the "Initial Conversion Price"). The Initial Conversion Price is subject to broad-based weighted average anti-dilution adjustment to account for certain issuances of securities at a purchase price less than the conversion price then in effect. In addition, the Initial Conversion Price is subject to certain price-based adjustments pursuant to the terms of the Certificate of Designation of the Preferences, Rights and Limitations of the Series C Convertible Preferred Stock (the "Certificate of Designation"). The exercise price of the Warrants is subject to broad-based weighted average anti-dilution adjustment to account for certain issuances of securities at a purchase price less than the exercise price with respect to the Warrants then in effect. The shares of Series C Preferred Stock will automatically convert into shares of Common Stock at the then-applicable conversion price on the date 60 days after the effective date of the Registration Statement (the "Effective Date"), subject to the satisfaction of certain conditions described in the Certificate of Designation (the "Automatic Conversion"). The shares of Series C Preferred Stock may be converted into shares of Common Stock at the option of the Buyers at any time prior to the Automatic Conversion. In the event that the Company is required to issue more than an aggregate of 833,333 shares of Common Stock (the "Company Limit") to effect the conversion of the shares of the Series C Preferred Stock into shares of Common Stock, Mr. Kraig Higginson, Chairman of the Board of Directors of the Company, has agreed to transfer to the Company up to an aggregate of 2 million shares of Common Stock in excess of the Company Limit. In the event that the conversion of the shares of Series C Preferred Stock results in the issuance by the Company of more than an aggregate of 2,833,333 shares of Common Stock (the "Aggregate Limit"), the Company is required to redeem out of legally available funds such shares of Common Stock issued by the Company in excess of the Aggregate Limit at the then-applicable conversion price. >>